Tokyo Tape
Sign in
← Terumo

Quarterly report · Q1

4543.TEDINET S100OZIL
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥197.3bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥703.3bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥171.7bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥30.4bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥36.2bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥29.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥114.5bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥36.0bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥88.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥27.9bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥27.9bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥1.58Tat 2022-06-30Cons.Assets IFRS
Total assets¥1.47Tat 2022-03-31Cons.Assets IFRS
Total assets¥1.34Tat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥466.9bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥461.4bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.12Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.01Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥874.0bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥856.7bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.12Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.01Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥874.0bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥209.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥186.7bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥200.8bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥23.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥141.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥29.9bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥16.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥78.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥21.0bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.8bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥70.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥23.1bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥29.612022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥117.452021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥36.92021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥29.62022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥117.382021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥36.872021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio70.5%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio68.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio65.2%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥62m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥198m
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥34.5bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥116.8bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥28.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥46.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥4.5bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥197.3bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥36.1bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-06-30¥64m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥1.6bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2021-04-01 → 2021-06-30¥28.3bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2021-04-01 → 2021-06-30¥6.0bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2021-04-01 → 2021-06-30¥99.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2021-04-01 → 2021-06-30¥29.4bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2021-04-01 → 2021-06-30¥43.8bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2021-04-01 → 2021-06-30¥6.4bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥171.7bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥41.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 562
ItemContextValueUnit
Bonds and borrowings cl IFRSCurrentQuarterInstant11931000000JPY
Other financial liabilities cl IFRSPrior1YearInstant7228000000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant7822000000JPY
Income taxes payable cl IFRSPrior1YearInstant14104000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant12961000000JPY
Provisions cl IFRSPrior1YearInstant499000000JPY
Provisions cl IFRSCurrentQuarterInstant457000000JPY
Other current liabilities cl IFRSPrior1YearInstant73222000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant72926000000JPY
Total current liabilities IFRSPrior1YearInstant177721000000JPY
Total current liabilities IFRSCurrentQuarterInstant183465000000JPY
Bonds and borrowings ncl IFRSPrior1YearInstant224875000000JPY
Bonds and borrowings ncl IFRSCurrentQuarterInstant223569000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant30297000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant31186000000JPY
Deferred tax liabilities IFRSPrior1YearInstant12746000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant13358000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant5811000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant6232000000JPY
Provisions ncl IFRSPrior1YearInstant113000000JPY
Provisions ncl IFRSCurrentQuarterInstant122000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant9813000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant8921000000JPY
Non current labilities IFRSPrior1YearInstant283658000000JPY
Non current labilities IFRSCurrentQuarterInstant283392000000JPY
Liabilities IFRSPrior1YearInstant461379000000JPY
Liabilities IFRSCurrentQuarterInstant466857000000JPY
Share capital IFRSPrior1YearInstant38716000000JPY
Share capital IFRSCurrentQuarterInstant38716000000JPY
Capital surplus IFRSPrior1YearInstant51921000000JPY
Capital surplus IFRSCurrentQuarterInstant51994000000JPY
Treasury shares IFRSPrior1YearInstant-6229000000JPY
Treasury shares IFRSCurrentQuarterInstant-6147000000JPY
Retained earnings IFRSPrior1YearInstant846978000000JPY
Retained earnings IFRSCurrentQuarterInstant855655000000JPY
Other components of equity IFRSPrior1YearInstant80926000000JPY
Other components of equity IFRSCurrentQuarterInstant176294000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant1012313000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant1116514000000JPY
Equity IFRSPrior1YearInstant1012313000000JPY
Equity IFRSCurrentQuarterInstant1116514000000JPY
Liabilities and equity IFRSPrior1YearInstant1473693000000JPY
Liabilities and equity IFRSCurrentQuarterInstant1583371000000JPY
Revenue IFRSPrior1YTDDuration171716000000JPY
Revenue IFRSCurrentYTDDuration197340000000JPY
Cost of sales IFRSPrior1YTDDuration77457000000JPY
Cost of sales IFRSCurrentYTDDuration95702000000JPY
Gross profit IFRSPrior1YTDDuration94259000000JPY
Gross profit IFRSCurrentYTDDuration101637000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration58140000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass